Davenport & CO LLC Bellerophon Therapeutics, Inc. Transaction History

Davenport & CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$3.83 - $5.65 $379,074 - $559,208	-98,975 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$5.07 - $8.27 $49,432 - $80,632	9,750 Added 10.93%	98,975 $514,000
Q4 2020 Jan 13, 2021	SELL	$6.12 - $10.37 $32,130 - $54,442	-5,250 Reduced 5.56%	89,225 $595,000
Q3 2020 Oct 15, 2020	SELL	$9.27 - $13.79 $117,497 - $174,788	-12,675 Reduced 11.83%	94,475 $962,000
Q2 2020 Jul 28, 2020	BUY	$9.43 - $20.28 $1.01 Million - $2.17 Million	107,150 New	107,150 $1.35 Million

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $573K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.